EUROPE: Generics will profit from healthcare cuts

You must be signed in to read this analysis

Sign in Sign up to our newsletter

In this article

  • Pharmaco-economics
  • Structural changes
  • United Kingdom
  • Germany
  • France
  • Greece
  • Pharmaceutical industry
  • Prices
  • Generics
  • Corruption

What is this?

This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.